Deceased Donor Organ Transplantation Performed in the United States for Noncitizens and Nonresidents. Read more about Deceased Donor Organ Transplantation Performed in the United States for Noncitizens and Nonresidents.
History of Marijuana Use Does Not Affect Outcomes on the Liver Transplant Waitlist. Read more about History of Marijuana Use Does Not Affect Outcomes on the Liver Transplant Waitlist.
Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Read more about Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
β Cell Replacement Therapy: The Next 10 Years. Read more about β Cell Replacement Therapy: The Next 10 Years.
Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients. Read more about Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot". Read more about Wait Time of Less Than 6 and Greater Than 18 Months Predicts Hepatocellular Carcinoma Recurrence After Liver Transplantation: Proposing a Wait Time "Sweet Spot".
Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction. Read more about Clinical Trials for Immunosuppression in Transplantation: The Case for Reform and Change in Direction.
Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection. Read more about Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma. Read more about Cost-Effectiveness of Direct-Acting Antiviral Treatment in Hepatitis C-Infected Liver Transplant Candidates With Compensated Cirrhosis and Hepatocellular Carcinoma.
